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Very long-chain fatty acids (VLCFAs) are essen-
tial lipids whose functional diversity is enabled
by variation in their chain length. The full VLCFA
biosynthetic machinery and how this machinery
generates structural diversity remain elusive.
Proteoliposomes reconstituted here from pu-
rified membrane components—an elongase
protein (Elop), a novel dehydratase, and two
reductases—catalyzed repeated rounds of
two-carbon addition that elongated shorter
FAs into VLCFAs whose length was dictated
by the specific Elop homolog present. Muta-
tional analysis revealed that the Elop active
site faces the cytosol, whereas VLCFA length
is determined by a lysine near the luminal end
of an Elop transmembrane helix. By stepping
the lysine residue along one face of the helix to-
ward the cytosol, we engineered novel syn-
thases with correspondingly shorter VLCFA
outputs. Thus the distance between the active
site and the lysine residue determines chain
length. Our results uncover a mutationally ad-
justable, caliper-like mechanism that generates
the repertoire of cellular VLCFAs.
INTRODUCTION
Very long-chain fatty acids (VLCFAs) are structurally di-
verse biological molecules with unusually long hydrocar-
bon chains, ranging from 20 to 36 carbons (C20–36) or
more (Leonard et al., 2004). These lipids perform essential
roles in a wide range of biological processes that cannot
be supported by the more common shorter fatty acids
(i.e., C16 and C18). For example, the chain length of cer-
tain VLCFAs allows them to simultaneously reside in
both leaflets of the lipid bilayer, thereby stabilizing highly
curved cellular membranes, such as those surrounding
nuclear pore complexes (Schneiter et al., 2004, 1996).Notably, the variation in VLCFA chain length across
different species and different tissues has enabled the
numerous functional specializations of these lipids. In
S. cerevisiae, for example, while C22 is able to support
the essential functions of VLCFAs, C26 is specifically
required for a variety of membrane-based processes, in-
cluding the formation of GPI lipid anchors and the traffick-
ing of proteins in the secretory pathway (Dickson et al.,
2006; Toulmay and Schneiter, 2007). Similarly, in mam-
mals, VLCFAs with lengths greater than C30 allow the
formation of a permeability barrier that is critical for the
normal structure and function of the skin (McMahon
et al., 2007; Vasireddy et al., 2007). Finally, VLCFAs and
their derivatives act as signaling molecules (e.g., arachi-
donic acid; Leonard et al., 2002) and are dominant lipid
constituents of certain tissues in animals (e.g., photo-
receptor cells and myelin; Poulos et al., 1992) and plants
(e.g., oils and waxes; Kunst and Samuels, 2003).
Efforts to understand the mechanistic principles en-
abling their structural diversity have been hampered by
the inability to reconstitute VLCFA synthesis from purified
components (Cinti et al., 1992; Jakobsson et al., 2006;
Leonard et al., 2004). This has been largely due to the insol-
uble nature of the VLCFA biosynthetic machinery which
has been known since the 1960s to consist of detergent-
labile complexes embedded within the endoplasmic retic-
ulum (ER) membrane (for a historical overview see Cinti
et al., 1992). These pioneering studies demonstrated that
VLCFAs are synthesized by the elongation of shorter fatty
acids (C16 and C18) that are produced in the cytosol by the
well-characterized, multienzyme complex termed the fatty
acid synthase (FAS; Jenni et al., 2007; Lomakin et al.,
2007). VLCFA synthesis was shown to proceed by a four-
step biochemical cycle (Figure 1B; Nugteren, 1965): (1)
condensation of malonyl-CoenzymeA (CoA) with an acyl-
CoA precursor; (2) reduction of the resulting 3-keto inter-
mediate; (3) dehydration of the 3-hydroxy species; and
(4) reduction of the enoyl product to yield a saturated FA
chain that is two carbons longer than its precursor.
The above conceptual framework facilitated more re-
cent genetic approaches in budding yeast that identified
several ER membrane proteins required for VLCFA pro-
duction. Specifically, Ybr159wp and Tsc13p are strongCell 130, 663–677, August 24, 2007 ª2007 Elsevier Inc. 663
candidates for the enzymes catalyzing the second and
fourth steps of the elongation cycle, respectively, as
they are homologous to known reductases and their inac-
tivation leads to the accumulation of the expected keto
and enoyl intermediates in the ER membrane (Beaudoin
et al., 2002; Han et al., 2002; Kohlwein et al., 2001). Addi-
tionally, Fen1p and Sur4p are two yeast members (Oh
et al., 1997) of a large family of proteins termed the Elops
(Jakobsson et al., 2006) which are required for the first
(condensation) step in the elongation cycle (Moon et al.,
2001; Paul et al., 2006; Westerberg et al., 2006). More-
over, heterologous expression of Elop homologs in yeast
demonstrated that these proteins determine the length
of cellular VLCFA products. Hence, the proliferation and
specialization of Elops has been responsible for the ob-
served VLCFA chain length diversity across different or-
ganisms and cell types (Jakobsson et al., 2006; Leonard
et al., 2004). The exact function of Elops in the elongation
cycle is uncertain, however, as these proteins lack homol-
ogy to known condensing enzymes. Therefore, it remains
to be established whether Elops are members of a novel
family of condensing enzymes or noncatalytic adapters
for recruiting specific substrates to the actual condensing
enzyme. Finally, no protein has been identified that is spe-
cifically required for the dehydratase reaction.
Based on these findings, we can now restate the ques-
tion of VLCFA chain length determination in more specific
mechanistic terms. Namely, how do Elops instruct the
components of the elongation cycle to extend shorter
FAs in two-carbon addition steps so as to yield VLCFA
products of defined lengths? The observation that ER
membranes containing a single Elop can convert sub-
strates of different lengths to the same-length end product
(Paul et al., 2006) argues against a length-determining
mechanism that ‘‘counts’’ a fixed number of two-carbon
additions. Conversely, ER membranes with different Elops
allow for the elongation of the same substrate to different-
length VLCFA products (Paul et al., 2006). Thus, Elops are
able to specify VLCFA length in absolute terms. Efforts to
understand the mechanism by which Elops achieve this
and how evolutionary diversification of the Elop family
has enabled the synthesis of VLCFAs of novel chain
lengths have been hampered by the incomplete inventory
of the components required for VLCFA synthesis (Paul
et al., 2006). Moreover, the integral membrane nature of
the enzymes involved has thus far obstructed the in vitro
reconstitution of any step of the elongation cycle (Cinti
et al., 1992; Jakobsson et al., 2006; Leonard et al., 2004).
Here we identify Phs1p as the VLCFA dehydratase and
show that it is the final missing component of the elonga-
tion cycle by reconstituting robust VLCFA synthesis using
purified Elops, Phs1p, Ybr159wp, and Tsc13p inserted
into proteoliposomes. Moreover, we demonstrate that
Elops are a novel family of condensing enzymes that spec-
ify VLCFA length by terminating processive rounds of the
elongation cycle following the synthesis of defined length
products. Finally, we exploit this reconstituted system to
elucidate the logic by which Elops measure VLCFA length664 Cell 130, 663–677, August 24, 2007 ª2007 Elsevier Inc.and use this understanding to rationally design VLCFA
synthase variants with dramatically altered product length
outputs.
RESULTS
Phs1p Is the Elongation Cycle Dehydratase
In our previous large-scale genetic interactions study of
the yeast early secretory pathway, we identified Phs1p
as a highly conserved ER protein with six predicted trans-
membrane segments that plays an essential role in sphin-
golipid metabolism (Schuldiner et al., 2005). Several ob-
servations suggested to us that Phs1p might be a core
component of the elongation cycle, the biosynthetic
source of VLCFA substrates critical for the production of
sphingolipids (Figure 1A). First, as expected following
a block in VLCFA synthesis (Figure 1A; Beaudoin et al.,
2002; Han et al., 2002; Kohlwein et al., 2001; Oh et al.,
1997), reduction in Phs1p levels resulted in the accumula-
tion of cellular long-chain bases (LCBs; Figure 2A). Sec-
ond, cells with reduced Phs1p levels fail to grow in the
presence of exogenously added myristic acid (C14)
when FAS is chemically inhibited (Figure 2B), a hallmark
of VLCFA mutants (Rossler et al., 2003). Lastly, Phs1p
coimmunoprecipitates with Fen1p, Sur4p, Ybr159wp,
and Tsc13p (Figure 2C).
To further define the role of Phs1p in fatty acid elonga-
tion, we incubated membranes that had been genetically
depleted of Phs1p with radiolabeled malonyl-CoA and un-
labeled C18-CoA in the presence of reducing cofactors
(essential for the second and fourth steps of the elongation
cycle). The products of this reaction were then separated
on the basis of chain length by reverse-phase thin-layer
chromatography. As previously seen (Paul et al., 2006),
wild-type membranes elongated C18-CoA up to C26
(Figure 2D), the most abundant VLCFA in S. cerevisiae
(Welch and Burlingame, 1973). In contrast, Phs1p-de-
pleted membranes were strongly compromised for elon-
gation and instead accumulated a fast-migrating (i.e.,
more hydrophilic) species (Figure 2D). Normal-phase
TLC, a method better suited for resolving elongation cycle
intermediates, identified this species as the 3-hydroxy in-
termediate (Figure 2E), which is the substrate for the third
step in the cycle (Figure 1B). Notably, the first two steps
(i.e., formation of the 3-keto intermediate in the absence
of NAD(P)H and its reduction in the presence of NAD(P)H,
respectively) were not compromised by Phs1p depletion
(Figure 2E). Thus, Phs1p is specifically required for the
dehydratase step of the elongation cycle.
As Phs1p lacks homology to known dehydratases, we
sought to determine if it catalyzes the third step of the
elongation cycle by purifying epitope-tagged Phs1p.
Strikingly, coincubation of either yeast- (Figure S1A) or
bacterially produced Phs1p (Figure S1B) and a 3-hydroxy
C18-CoA dehydratase substrate (Figure S2A) resulted in
accumulation of the dehydrated enoyl-CoA (Figures 2F,
S2B, and S2C). Taken together, these data establish
that Phs1p is the founding member of a novel and
conserved family of membrane dehydratases that cata-
lyze the third step of the elongation cycle. Previous ge-
netic studies have shown that mutations in close PHS1
homologs cause tumorigenesis in plants (Bellec et al.,
2002; Da Costa et al., 2006) and centronuclear myopathy
in a canine model for this human disease (Pele et al.,
2005). The elucidation of the molecular role of Phs1p
now points to the involvement of VLCFAs in these pro-
cesses.
Elops Are VLCFA Condensing Enzymes
To explore the role of Elops in the condensation reaction,
we overexpressed and purified functional epitope-tagged
versions of Fen1p and Sur4p, two yeast Elops (Figure
S3A), but failed to detect significant condensation
Figure 1. Fatty Acid and Sphingolipid Metabolism in S. cere-
visiae
(A) Long-chain (C16 and C18) fatty acids (LCFAs) made by fatty acid
synthase (FAS) are precursors for the synthesis of long-chain bases
(LCBs) and very long-chain fatty acids (VLCFAs), the two substrates
for ceramide synthesis.
(B) The chemical reactions of the elongation cycle and the identity of
yeast proteins required for each step.activity in our detergent-solubilized preparations (data
not shown). We therefore removed the detergent in the
presence of synthetic phospholipids of a defined compo-
sition approximating that of the ER membrane (Matsuoka
and Schekman, 2000). Remarkably, the resulting proteo-
liposomes, containing either Fen1p or Sur4p (Figure S3B),
catalyzed formation of the 3-keto product (Figure 3A).
We next explored the mechanism by which Elops
catalyze the condensation reaction. These membrane-
embedded proteins lack an absolutely conserved cyste-
ine-containing catalytic triad found in the condensing
enzymes of FAS and FAS-like systems (Paul et al., 2006).
Moreover, the cysteine-targeted FAS inhibitor cerulenin
does not interfere with VLCFA synthesis (Figure 2B).
We therefore examined absolutely conserved signature
sequence motifs within the Elop family (Jakobsson et al.,
2006) for their possible involvement in catalyzing the con-
densation reaction. Experimental analysis of Elop mem-
brane topology (Figure 3B, see legend for details) raised
the possibility that all Elop signature motifs were located
within either a cytosolic loop or juxta-cytosolic transmem-
brane helix (TMH) regions (Figure 3B) and thus might be
organized into a catalytic ring surrounding the entrance
of an intramembrane substrate-binding pocket. Our atten-
tion was specifically drawn to the HXXHH motif that was
proximal to several absolutely conserved lysine and argi-
nine residues which, by analogy to other CoA-binding
condensing enzymes, might interact with the phosphate
moieties of CoA (Ferrer et al., 1999), thereby orienting
the substrate for catalysis. Mutational analysis revealed
that the HXXHH motif is not required for Elop incorporation
into a multiprotein complex and thus is likely not critical for
global folding (Figures 3C and S3C). However, this motif is
essential for Elop function in vivo (Figure 3D) and 3-keto
acyl-CoA synthase activity in vitro (Figure 3E; data not
shown). While the experimental tools for determining the
topology of membrane proteins are imperfect, other inde-
pendent considerations argue that the Elop active site is
located in or near the cytosol. Specifically, members of
an unrelated family of plant condensing enzymes known
to have a cytosolic active site, when expressed in yeast,
are able to engage the core components of the elongation
cycle machinery and bring about VLCFA synthesis (Paul
et al., 2006). Additionally, VLCFA synthesis depends on
malonyl-CoA synthesized by a cytosolic acetyl-CoA car-
boxylase (Ivessa et al., 1997). Collectively, these findings
argue that Elops use a novel condensation mechanism
to initiate two-carbon addition in (or near) the cytosol.
Reconstitution of the Complete Elongation Cycle
from Purified Components
We next used the reconstituted condensation reaction to
explore the mechanism by which different Elops specify
the chain length of VLCFAs. An earlier study (Oh et al.,
1997) demonstrated that Dsur4 cells have undetectable
levels of C26, the major budding yeast VLCFA species,
and instead accumulate C22 as their longest VLCFA.Cell 130, 663–677, August 24, 2007 ª2007 Elsevier Inc. 665
Figure 2. Phs1p Catalyzes the Third Step of the Elongation Cycle
(A) Wild-type cells or cells with Phs1p under the transcriptional control of the tetracycline-repressible promoter (downward arrow) were treated with
doxycycline (a tetracycline derivative). Cellular LCBs were fluorescently labeled and analyzed by reverse-phase HPLC. * is the free fluorescent dye
remaining after the labeling procedure. Chromatogram peaks correspond to various structurally diverse LCB species (data not shown).
(B) Serial dilutions (vertical dimension) of the indicated strains (horizontal dimension) were spotted onto plates containing glucose,/+ cerulenin (cer),
and myristic acid (C14). phs1 refers to a strain with GAL1 promoter-driven expression of PHS1 from its genomic locus. Promoter shutoff in the pres-
ence of glucose is incomplete and results in a partial loss-of-function phs1 allele (data not shown).
(C) Cells expressing Myc-tagged proteins from their genomic loci and either Phs1p or Phs1-FLAG on a plasmid (covering Dphs1), as indicated, were
lysed and solubilized with digitonin. Following ultracentrifugation and immunoprecipitation (IP) with antiFLAG beads, bound material and input666 Cell 130, 663–677, August 24, 2007 ª2007 Elsevier Inc.
Notably, overexpression of Fen1p in these cells resulted
in some C24 production but failed to restore C26. On
the other hand, Dfen1 cells still had a significant level of
C26 remaining compared to wild-type cells and this
amount was increased by overexpression of Sur4p. A
simple molecular explanation for these in vivo observa-
tions is that Sur4p is uniquely able to recruit C24 for
VLCFA condensation in yeast. We were, however, sur-
prised to find that both Fen1p and Sur4p efficiently cata-
lyzed the condensation of substrates 16, 18, and 20 car-
bons long but showed limited reactivity toward longer
substrates (Figure 4A).
How then is Sur4p able to support the repeated elonga-
tion of shorter substrates to yield C26 when, like Fen1p, it
is unable to accept externally added C22/24 substrates?
A possible explanation for this apparent discrepancy is
that C26 synthesis occurs processively, such that Sur4p
efficiently catalyzes condensation of only those C22/24
substrates that are channeled from the fourth step of a pre-
ceding elongation cycle. To address this issue and, more
broadly, to enable the mechanistic exploration of VLCFA
synthesis, we reconstituted the complete elongation cycle
in vitro. We first purified epitope-tagged versions of
Ybr159wp and Tsc13p (Figure S4A) as they were excellent
candidates for the keto and enoyl reductase (Beaudoin
et al., 2002; Han et al., 2002; Kohlwein et al., 2001),
respectively. Incubation of proteoliposomes containing
Sur4p alone with C18-CoA and radiolabeled malonyl-
CoA generated the expected 3-keto C20 condensation
product (Figure 4B). Under the same conditions, proteoli-
posomes containing Ybr159wp, Phs1p, and Tsc13p re-
sulted in minimal incorporation of the label (Figure 4B).
Strikingly, proteoliposomes reconstituted with Sur4p to-
gether with Ybr159wp, Phs1p, and Tsc13p supported
four sequential rounds of elongation culminating with the
production of a C26 product (Figure 4B). Time-course
analysis revealed that C26 was present at even the earliest
time point and its ratio to intermediate products, which as
evidenced by normal-phase and argentation TLC analysis
correspond to saturated shorter VLCFAs (Figure S4B), did
not change significantly during the course of Sur4p-medi-
ated elongation (Figure 4C). These observations are con-
sistent with a processive elongation mechanism that re-leases a minor fraction of intermediates that are not
efficiently re-engaged by the elongation machinery. In
support of this interpretation, we did not observe efficient
engagement of externally added substrates longer than
C20 with either Sur4p reconstituted alone (Figure 4A) or
together with the remaining elongation cycle components
(Figure S4C). Collectively, these findings suggest that
Sur4p specifies VLCFA length by efficiently terminating
a processive elongation mechanism following the produc-
tion of the C26 end product.
We next explored the utility of our reconstituted system
for studying other Elops. Substituting Fen1p for Sur4p in
our fully reconstituted system resulted in the elongation
of either C16-CoA (Figure 4D) or C18-CoA (Figure 4E) to
C22 (and to a lesser extent C24), thus recapitulating the
VLCFA output of Fen1p in vivo. To more broadly test the
flexibility of our in vitro system, we purified (Figure S4D),
using our yeast expression system, the recently identified
T. brucei Elop homolog, TbElo1p (Lee et al., 2006). As ex-
pected, Fen1p was unable to instruct the elongation of C4
and C6 precursors (Figure 4D). These short substrates
were, however, efficiently elongated to the C10 product
in the presence of TbElo1p as the source of the condens-
ing activity (Figure 4D). This is in agreement with RNAi
studies showing that TbElo1p is required for the synthesis
of C10 in T. brucei (Lee et al., 2006). Taken together, these
data establish that Ybr159wp, Phs1p, and Tsc13p act to-
gether as a versatile catalytic platform for the engagement
of Elop condensing modules which specify the chain
length of VLCFAs in the cell.
To further examine the suitability of our reconstituted
system for studying the process of fatty acid elongation
in vitro, we compared the elongation activity of ER-derived
microsomes to that of proteoliposomes containing com-
parable amounts of the corresponding elongation cycle
components (Figure 4E, see legend for details). Under
conditions where VLCFA products were monitored using
radiolabeled malonyl-CoA, proteoliposomes were signifi-
cantly more efficient than microsomes at elongating the
unlabeled acyl-CoA primer (Figure 4E). We observed a
similar phenomenon when we used a radiolabeled primer
with an excess of unlabeled malonyl-CoA (Figure 4F),
a tracer approach better suited for measuring the fractionfractions were resolved by SDS-PAGE followed by western analysis (W) with the indicated antibodies. Note that only full-length Tsc13p (*) was effi-
ciently pulled down by Phs1-FLAG.
(D) Wild-type or genetically depleted Phs1p membranes (see Supplemental Experimental Procedures) were incubated with radiolabeled malonyl-CoA
and unlabeled C18-CoA in the presence of reducing cofactors. Acyl-CoA reaction products were converted into FA methyl esters, resolved by re-
verse-phase TLC, and detected by phosphorimager analysis. * is the fast-migrating species that accumulated specifically in Phs1p-depleted mem-
branes. Both membrane preparations lead to comparable incorporation of the label into species migrating faster than C20 (one of which comigrates
with *) that disappeared upon preincubation of membranes with cerulenin (data not shown) and thus most likely represent LCFAs produced by cop-
urifying FAS in our membrane preparations.
(E) Membranes, prepared as in (C), were incubated with radiolabeled malonyl-CoA and unlabeled C20-CoA (similar results were seen using C18-CoA
as the substrate, data not shown) in the absence or presence of reducing cofactors, NAD(P)H, as indicated. Acyl-CoA reaction products were
converted into free FAs, resolved by normal-phase TLC, and detected by phosphorimager analysis.
(F) Purified Phs1-FLAG (yeast source), Phs1-HIS (bacterial source), or the corresponding mock elutions were incubated with a 3-hydroxy C18-CoA
dehydratase substrate. CoA-containing molecules were fluorescently labeled and analyzed by reverse-phase HPLC. * is a nonspecific derivatization
breakdown product of 3-hydroxy C18-CoA (data not shown).Cell 130, 663–677, August 24, 2007 ª2007 Elsevier Inc. 667
Figure 3. Elops Are a Novel Family of Membrane Condensing Enzymes
(A) Wild-type membranes or proteoliposomes reconstituted with purified Fen1-FLAG or Sur4-FLAG were incubated with radiolabeled malonyl-CoA
and unlabeled C18-CoA in the absence or presence of reducing cofactors, NAD(P)H, as indicated. Product analysis was carried out as in Figure 2E.
No attempt was made to normalize the amount of purified Elops to their amount in microsomes (for a better comparison see Figures 4E and 4F).
(B) The depicted seven-pass arrangement of Sur4p’s TMHs is based on a prediction from a global topology analysis of the yeast membrane proteome
(Kim et al., 2006). The boxed regions correspond to the approximate positions of the Elop signature motifs (the HXXHH motif is colored green). The
dibasic sequence near the C terminus of Sur4p is likely to be recognized by the cytosolic ER-retrieval machinery. The numbers indicate the amino acid
positions at which the dual topology reporter (DTR) was inserted. Briefly, only strains in which the DTR is inserted within a cytosolic region are able to
grow on SD-His plates containing histidinol. Whole-cell lysates from the indicated strains were either mock treated () or deglycosylated with Endo-
glycosidase H (EndoH, +) and resolved by SDS-PAGE. Western analysis (W) of the DTR HA3 epitope revealed the glycosylation status of the fusion
proteins as only insertion of the DTR within a luminal region leads to hyperglycosylation of the fusion protein.
(C) Cells expressing Fen1-Myc from its genomic locus and carrying empty vector () or vectors expressing FLAG-tagged wild-type and mutant ver-
sions of Fen1p and Sur4p, as indicated, were lysed and solubilized with digitonin. Following ultracentrifugation and IP with antiFLAG beads, bound
material and input fractions were resolved by SDS-PAGE followed by western analysis (W) with the indicated antibodies.
(D) Dfen1Dsur4 cells carrying a URA-marked vector expressing Fen1-FLAG were transformed with an empty TRP-marked vector (vec) or one ex-
pressing a wild-type or mutant version of Fen1-FLAG and Sur4p-FLAG, as indicated. Following plasmid shuffle, cells were spotted onto the indicated
plates. In the absence of both Elop activities, cells are unable to survive on 5-FOA.
(E) Proteoliposomes reconstituted with purified Fen1-FLAG or Fen1 H181A-FLAG were incubated with radiolabeled malonyl-CoA and unlabeled C18-
CoA. Product analysis was carried out as in Figure 2E. Western analysis (W) revealed the amounts of wild-type and mutant Fen1-FLAG in the assay.668 Cell 130, 663–677, August 24, 2007 ª2007 Elsevier Inc.
of the primer that gets converted to longer products. One
possible explanation for the lower elongation efficiency of
microsomes is that other biochemical systems in the ER
membrane preparation siphon away substrates from the
elongation machinery. Supporting this argument is the
presence of multiple nonVLCFA products in the micro-
some reaction (Figures 4E and 4F) that are absent from
our reconstituted system and most likely represent off-
pathway species. Moreover, increasing the microsome
concentration further decreased the efficiency of FA elon-
gation (Figure 4E), whereas raising the Elop concentration
in the in vitro system allowed for a virtually quantitative
conversion of substrate to the final VLCFA product
(Figure S4E). These data argue that we have biochemi-
cally defined the full complement of elongation cycle
components.
The Molecular Logic of VLCFA Length
Determination
The reconstitution of fatty acid elongation allowed us to ad-
dress two critical mechanistic issues pertaining to VLCFA
synthesis. Namely, how do individual Elops specify the
length of a VLCFA molecule, and what features of this
mechanism make it well suited for evolving homologous
mechanisms that enable VLCFA chain length diversity?
To this end, we made chimeras between Fen1p and
Sur4p, as these two Elops instructed in vitro the elongation
of a C18-CoA substrate to C22 and C26, respectively. Ini-
tial in vivo screening of our chimeric constructs using gas
chromatography coupled to product identification by
mass spectrometry (GC/MS) established that the region
of Sur4p extending from the middle of the sixth TMH
(TMH6) to the C terminus contains sequence elements
that are both necessary and sufficient for Sur4p’s ability
to produce C26 (Figure 5A, compare chimeras I and II). Fur-
ther refinement of this chimeric approach revealed that just
two blocks of seven amino acids, mapping to the opposing
luminal ends of Sur4p TMHs 6 and 7, were sufficient to re-
capitulate this transformation (Figure 5A, compare chi-
meras II, III, and IV). Enzymatic analysis using the reconsti-
tuted system directly demonstrated that a Fen1p chimera
containing the critical Sur4p juxta-luminal TMH residues
supported the elongation of C18-CoA to C26 (Figure 5B).
Collectively, these data argue that, in contrast to new chain
growth by two-carbon addition on the cytosolic side, the
final chain length output of the membrane-embedded
VLCFA synthase is specified by TMH regions proximal to
the luminal face of the membrane.
To identify which juxta-luminal TMH residues are critical
for determining VLCFA chain length, we aligned Elop ho-
molog sequences from several yeast species. Notably,
a residue near the luminal end of the TMH6, which we arbi-
trarily define as the 0 position (TMH6[0]), is occupied by
a lysine residue that was conserved, but only in members
of the Sur4p-like subfamily (Figure 6A). In contrast, mem-
bers of the Fen1p-like subfamily have a lysine at the nearby
4 position (TMH6[4]; i.e., four residues from 0 toward
the cytosolic N-terminus of TMH6), while Sur4p and its ho-mologs have a phenylalanine at the corresponding posi-
tion (Figure 6A). To test whether these differences are func-
tionally relevant for specifying the terminal length of VLCFA
products, we purified a Sur4p mutant (F262K/K266L) con-
taining the corresponding Fen1p residues at positions
TMH6(0) and (4). Strikingly, while Sur4p instructed the
synthesis of the expected C26 product, the lysine-swap
Sur4p mutant behaved like Fen1p and terminated elonga-
tion following the production of C22 (and to a lesser extent
C24; Figure 6B). Consistent with this observation in vitro,
GC/MS analysis revealed dramatically diminished C26
levels in Dsur4 cells expressing this mutant (Figure 6C).
Therefore, placement of a conserved Sur4p TMH6 lysine
residue closer to the site of two-carbon addition in the cy-
tosol resulted in a shortening of the final VLCFA product.
The unusual presence of conserved lysine residues
within an Elop TMH led us to more carefully examine their
structural context. Notably, the spacing between TMH6(0)
and (4) places the lysines on the same face of the TMH6
alpha helix (Figure 7A). This helical arrangement is likely to
be functionally relevant, as placing a lysine residues at
TMH6(2), a position on the opposite face of this helix
(Figure 7A), did not cause Sur4p to terminate extension
prior to reaching the C26 length (data not shown). We
therefore examined the possibility that these lysines might
be facing an intramembrane substrate-binding pocket
that accepts a growing VLCFA chain. To this end, we
shifted the lysine residue to positions TMH6(8) and
(11) of Fen1p, locations that reside on the same face of
the TMH6 but at two successive turns of the helix closer
to the cytosol (Figure 7A). As expected, wild-type Fen1p
enabled extension of either a C14 or a C16 substrate
to C22 in vitro (Figure 7B). In contrast, the purified
TMH6(8) Fen1p mutant terminated elongation of both
substrates following production of C18 and did not act
on longer substrates (Figure 7B; data not shown). Further
underscoring the idea that the distance between the juxta-
luminal lysine residue and the cytosol determines VLCFA
length, we observed that the TMH6(11) Fen1p mutant
elongated C14 to C16 but was unable to extend C16
(Figure 7B). Lastly, we attempted to expand the biosyn-
thetic repertoire of yeast Elops by removing bulky resi-
dues from this region of Sur4p. Remarkably, a Sur4p mu-
tant with smaller and uncharged residues at positions
TMH6(0) and (4) instructed the synthesis of a product
longer than C26 in vitro (Figure 7C) that we confirmed by
GC/MS analysis in vivo corresponded to a novel C30 spe-
cies (Figure 7D). Thus, targeted mutations in Elops can be
used to predictably engineer VLCFA synthesis over a
remarkably broad range of chain lengths.
DISCUSSION
Many complex biological molecules are synthesized as
polymers from identical or structurally similar building
blocks (Alberts et al., 2002). While well-suited for the pro-
duction of chemical diversity, polymerization reactions
pose a challenge to the enzymatic machinery that mustCell 130, 663–677, August 24, 2007 ª2007 Elsevier Inc. 669
Figure 4. Reconstitution of the Elongation Cycle with Purified Membrane Components of the Endoplasmic Reticulum
(A) Proteoliposomes reconstituted with purified Fen1-FLAG or Sur4-FLAG were incubated with radiolabeled malonyl-CoA and unlabeled acyl-CoAs of
different lengths, as indicated. Products were analyzed as in Figure 2E.
(B) Proteoliposomes reconstituted with the indicated purified proteins were incubated with radiolabeled malonyl-CoA and unlabeled C18-CoA. Prod-
ucts were analyzed as in Figure 2D. Western analysis revealed comparable concentrations of the corresponding proteins in the partial and fully
reconstituted reactions (data not shown).
(C) Proteoliposomes reconstituted with purified Sur4-FLAG, Ybr159w-FLAG, Phs1-FLAG, and Tsc13-FLAG were incubated with radiolabeled
malonyl-CoA and unlabeled C18-CoA. Products were removed at the indicated times and analyzed as in Figure 2D. Quantitation revealed that
the C26 signal comprised 55%–70% of the total at all times.670 Cell 130, 663–677, August 24, 2007 ª2007 Elsevier Inc.
Figure 5. Luminal Elop TMH Regions Specify the Length of VLCFAs
(A) FA species from Dsur4 cells expressing wild-type Fen1p or the indicated chimeras on a plasmid were converted into fatty acid methyl esters
(FAMES), extracted, and analyzed by GC/MS. The retention times of VLCFAMESs in the top row chromatograms are slightly different from those
in the bottom row due to analysis by different GC columns. All constructs were expressed at comparable levels (data not shown).
(B) Proteoliposomes reconstituted with purified Ybr159w-FLAG, Phs1-FLAG, and Tsc13-FLAG along with either Fen1-FLAG or Fen1 chimera
IV-FLAG (from [A]) were incubated with radiolabeled malonyl-CoA and C18-CoA, as indicated. Products were analyzed as in Figure 2D.employ these iterative processes to synthesize molecules
of defined lengths. In the case of DNA replication, tran-
scription, and mRNA translation, the addition of eachmonomer is catalyzed by repeated use of the same cata-
lytic machinery, and the problem of length determination
is solved using an informational template with a defined(D) Proteoliposomes reconstituted with purified Ybr159w-FLAG, Phs1-FLAG, and Tsc13-FLAG along with either Fen1-FLAG or TbElo1-FLAG were
incubated with radiolabeled malonyl-CoA and unlabeled acyl-CoAs of different lengths, as indicated. Products were analyzed as in Figure 2D.
(E) ER-derived microsomes were prepared from Dphs1 cells expressing Phs1-FLAG on a plasmid. Proteoliposomes were reconstituted with purified
Fen1p-FLAG, Ybr159w-FLAG, Phs1-FLAG, and Tsc13-FLAG. The concentration of Phs1-FLAG in the microsomes was adjusted to the concentration
of Phs1-FLAG in the proteoliposomes by western analysis (W). x refers to a normalized unit of Phs1-FLAG expression in the two elongation systems.
The other elongation cycle components in the proteoliposomes were present at approximately equimolar levels relative to Phs1-FLAG (data not
shown). Following incubation with radiolabeled malonyl-CoA and unlabeled C18-CoA, products were analyzed as in Figure 2D.
(F) Membranes and proteoliposomes, prepared and normalized as in (E), were incubated with radiolabeled C16-CoA and unlabeled malonyl-CoA.
Products were analyzed as in Figure 2D. Note that the dominant microsomal reaction product (*) migrates faster (i.e., is more hydrophilic) than the
C16-CoA precursor.Cell 130, 663–677, August 24, 2007 ª2007 Elsevier Inc. 671
Figure 6. Conserved Lysine Residues near the Luminal End of TMH6 Determine the Chain Length Output of VLCFA Synthase
(A) ClustalW alignment of yeast Elop homolog sequences revealed one subfamily with members more closely related to Fen1p and another with mem-
bers more closely related to Sur4p (data not shown). Shown here is the region of the full alignment corresponding to the luminal end of TMH6. S.c.
indicates S. cerevisiae; C.g. indicates C. glabrata; K.l. indicates K. lactis; and A.g. indicates A. gossypii.
(B) Proteoliposomes reconstituted with purified Ybr159w-FLAG, Phs1-FLAG, and Tsc13-FLAG along with either wild-type Sur4-FLAG or Sur4 F262K/
K266L-FLAG mutant were incubated with radiolabeled malonyl-CoA and C18-CoA, as indicated. Products were analyzed as in Figure 2D.
(C) Dsur4 cells expressing either wild-type Sur4-FLAG or Sur4-FLAG F262K/K266L were analyzed as in Figure 5A. Western analysis (W) of cellular
expression levels of wild-type and mutant (mut) Sur4-FLAG relative to hexokinase (HXK).beginning and end. In contrast, each round of elongation
during polyketide and nonribosomal peptide synthesis is
typically catalyzed by a different set of enzymes (Cane
et al., 1998). In this assembly-line strategy, a growing poly-
mer chain moves along a large, multifunctional synthase
whose number of catalytic modules determines the length672 Cell 130, 663–677, August 24, 2007 ª2007 Elsevier Inc.of the product. VLCFAs, however, are a structurally di-
verse class of molecules whose lengths are specified by
a distinct strategy. Here, every four-step round of mono-
mer addition is mediated by the same set of active sites,
yet there is no external template for guiding VLCFA syn-
thesis. Thus, the information necessary for specifying
Figure 7. Engineering the Chain Length Output of VLCFA Synthase
(A) Three-dimensional representation of an alpha helix depicting the relative positions of residues mutated in this study.
(B) Proteoliposomes reconstituted with purified Ybr159w-FLAG, Phs1-FLAG, and Tsc13-FLAG along with either wild-type Fen1-FLAG or the Fen1-
FLAG TMH6(8) (A251K/K255F) and TMH6(11) (I248K/K255F) mutants were incubated with radiolabeled malonyl-CoA and acyl-CoAs of different
lengths, as indicated. Products were analyzed as in Figure 2D.
(C) Proteoliposomes reconstituted with purified Ybr159w-FLAG, Phs1-FLAG, and Tsc13-FLAG along with either wild-type Sur4-FLAG or Sur4 F262A/
K266L-FLAG mutant were incubated with radiolabeled malonyl-CoA and C20-CoA (similar results were observed with C18-CoA, data not shown), as
indicated. Products were analyzed as in Figure 2D.
(D) Dsur4 cells expressing wild-type Sur4-FLAG or Sur4-FLAG F262A/K266L mutant were analyzed as in Figure 5A. The retention times are different
from those in the other figures because the elution gradient was modified to facilitate separation of VLCFA species longer than C26. Western analysis
(W) of cellular expression levels of wild-type and mutant (mut) Sur4-FLAG relative to hexokinase (HXK).
(E) Model depicting how Elops act as molecular calipers to specify VLCFA length. See text for details.Cell 130, 663–677, August 24, 2007 ª2007 Elsevier Inc. 673
product length must be contained within the biosynthetic
machinery itself. This is similar to the problem faced by the
FAS complex. In this case, a growing fatty acid chain is co-
valently attached to FAS, and elongation is terminated
when an enzyme within the complex severs the chain
attachment following production of C16 and C18 (Smith
et al., 2003). VLCFA synthesis, however, must rely on a dif-
ferent solution to the length-determination problem, as
there appears to be no covalent attachment of elongation
substrates to the biosynthetic machinery (Cinti et al.,
1992). How then does this machinery guide the synthesis
of a VLCFA molecule from beginning to end, and what mo-
lecular principles allow structural diversification of the
elongation mechanism leading to the production of new
VLCFA species?
Our studies reveal a caliper-like mechanism in which
different Elops measure VLCFA length as the distance be-
tween a fixed active site and a physically distinct region,
subject to mutational ‘‘sliding,’’ that detects the FA methyl
end (Figure 7E). Specifically, we have shown that catalysis
of the condensation step occurs on the cytosolic face of
the ER membrane, whereas lysine residues near the lumi-
nal end of an Elop TMH (TMH6) specify chain length. We
propose that the acyl moiety of a substrate is inserted in
the membrane, such that the repetitive addition of two-
carbon units in the cytosol results in the progressive dis-
placement of a substrate’s methyl end across the lipid bi-
layer toward the luminal face. The distance between the
active site and the juxta-luminal lysine is approximately
equal to the length of the terminal VLCFA product, arguing
that termination of elongation is triggered upon the methyl
end reaching the hydrophilic end of the pocket, as demar-
cated by a lysine residue. We tested this idea by stepping
the lysine residue along one face of TMH6 toward the cy-
tosol. When we did this for two successive turns, termina-
tion occurred earlier and led to the synthesis of VLCFA
products four (C22) and eight (C18) carbons shorter, re-
spectively, than the wild-type C26 length. Moreover, the
elimination of bulky residues from this juxta-luminal face
of TMH6 resulted in the production of a longer C30 spe-
cies. Consistent with the notion that this is a physical mea-
suring device, the distance between residues separated
by one helical turn (5.4 A˚) is in excellent agreement with
the length of a four-carbon unit along a saturated hydro-
carbon chain (5.3 A˚). As yeast Elops do not efficiently ac-
cept substrates shorter than C14 (data not shown), we
were unable to fully test this apparent ‘‘rule of fours’’ for
products shorter than C18. However, positioning the ly-
sine residue an additional rung closer to the cytosol re-
sulted in an even lower chain length output characterized
by reduced conversion of C14 to C16 and a complete in-
ability to extend C16. Intriguingly, RNAi studies in trypano-
somes have assigned the successive elongation of C4–
C10, C14, and C18 to the tandem activity of three Elop
homologs (Lee et al., 2006). The fact that TbElops instruct
the synthesis of VLCFA products whose lengths vary in
successive four-carbon steps raises the possibility that,
despite significant sequence divergence from their yeast674 Cell 130, 663–677, August 24, 2007 ª2007 Elsevier Inc.counterparts, TbElops also use an alpha helix-based mea-
suring strategy for specifying VLCFA chain length. Our
development of an in vitro system that works efficiently
with Elop homologs from distant organisms, including
a trypanosome Elop, should facilitate experimental inves-
tigation of this question as well as identification of other
molecular measuring strategies that enable elongation of
unsaturated (Beaudoin et al., 2000) and branched sub-
strates (Kniazeva et al., 2004).
On a practical note, our findings should facilitate ongo-
ing efforts to manipulate VLCFA synthesis in vivo. First,
there has been a great deal of interest in engineering
plants to produce nutritionally enhanced oils to serve as
a sustainable source of therapeutically (e.g., omega-3)
and commercially (e.g., erucic acid) valuable VLCFAs
(Graham et al., 2007; Puyaubert et al., 2005). Transgenic
overexpression of the full complement of elongation cycle
components, including the long-sought-after VLCFA de-
hydratase, might now yield plant oils with higher VLCFA
content than those previously obtained by overexpression
of only a subset of the components (Wu et al., 2005).
Moreover, rational design of Elop mutants, as illustrated
here, now offers a new toolkit for expanding the VLCFA
biosynthetic repertoire in order to generate plant
factories of ‘‘unnatural’’ products with potentially novel
bioactivities.
Second, human peroxisomal disorders are associated
with alterations in VLCFA metabolism (Poulos et al.,
1992). Specifically, adrenoleukodystrophy (ALD) is caused
by severe demyelination of the nervous system resulting
from increased production of saturated C26 fatty acids
(Kemp et al., 2005; Tsuji et al., 1984). Attempts at amelio-
rating this disease by inhibiting the elongation process
with a diet enriched in shorter monounsaturated species
(‘‘Lorenzo’s oil’’) have suffered from our rudimentary
understanding of what constitutes a selective Elop
inhibitor. Namely, while this treatment normalizes the
levels of saturated C26 fatty acids in ALD patients, this
is accompanied by a concomitant increase in very long
monounsaturated species and a failure to halt neurode-
generation (Kemp et al., 2005).
Finally, in conjunction with the recent discovery of T.
brucei Elop homologs that instruct the synthesis of short
fatty acids critical for GPI anchoring of variable surface
glycoproteins used by this parasite to evade the immune
system (Lee et al., 2006), our work also suggests new av-
enues for development of antisleeping sickness drugs.
Specifically, here we have shown that Elops catalyze the
chemically well-understood Claisen-like condensation
reaction, albeit with a novel requirement for the HXXHH
motif, and that a trypanosome homolog is able to instruct
the synthesis of short-chain fatty acids in vitro. Intrigu-
ingly, the HXXHH motif is known to coordinate metal
ions in other proteins (Shanklin et al., 1994). Assuming
a similar ion requirement during Elop-mediated catalysis,
selective inhibition of TbElops might be achieved using
a small molecule comprising a short hydrocarbon chain
attached to a metal-chelating group. Rational design of
such TbElop inhibitors could avoid side effects by a ‘‘dou-
ble-sieve’’ strategy: FAS is spared since it does not rely on
the HXXHH motif for catalysis, and inhibition of endoge-
nous VLCFA systems is avoided since mammalian Elops
do not act on short-chain substrates. A similar logic can
be applied to the development of more selective drugs
for treating other diseases caused by trypanosomatids.
Specifically, the various parasite species responsible for
the different types of leishmaniasis each have 14 Elop
homologs (Livore et al., 2007) that might be great pharma-
cological targets in the treatment of these otherwise ne-
glected diseases (Pecoul, 2004). More broadly, our ability
to generate large quantities of pure and active Elops from
a yeast expression system should facilitate future struc-
tural and mechanistic studies of this family of proteins
that may lead to more effective VLCFA-targeted therapeu-
tic strategies.
EXPERIMENTAL PROCEDURES
Yeast Strains and Plasmids
All strains were derivatives of W303 and S288C. The open reading
frames of FEN1, SUR4, and PHS1 were deleted by one-step PCR dis-
ruption. C-terminal epitope taggings, promoter taggings, and Elop chi-
meras were made by standard PCR-based techniques. Topology
mapping of Sur4p was performed by an extension of the approach
described in Kim et al. (2006).
Protein Purifications, Proteoliposome Reconstitutions, and
Elongation Cycle Assays
FLAG-tagged proteins were overexpressed in yeast using the 2 m
plasmid or the TDH3 promoter. Cells were lysed by bead beating
in HIB (50 mM HEPES-KOH 6.8, 150 mM KOAc, 2 mM MgOAc, and
1 mM CaCl2) containing 0.2 M sorbitol and protease inhibitors. ER-
derived membranes were isolated and solubilized with either 1% Triton
X-100 or 2% digitonin as described in Denic et al. (2006) with some
modifications. Purified proteins were reconstituted into proteolipo-
somes by removing detergent with SM2 Bio-Beads in the presence
of synthetic phospholipids of a defined composition approximating
that of the yeast ER membrane (11 mol% 1-palmitoyl-2-oleoyl-phos-
phatidylcholine [PC], 42 mol% dioleoyl-PC, 5 mol% 1-palmitoyl-2-
oleoyl-phosphatidylethanolamine [PE], 18 mol% dioleoyl-PE, 4 mol%
1-palmitoyl-2-oleoyl-phosphatidylserine [PS], 4 mol% dioleoyl-PS,
7 mol% phosphatidyl inositol, 4 mol% phospatidyl inositol-4-phos-
phate, and 5 mol% dioleoyl phosphatidic acid). Proteoliposomes
were pelleted by ultracentrifugation, analyzed by western analysis,
and assayed for elongation activity. Further details, as well as the
description of the bacterial purification of Phs1p, the dehydratase
assays, and the coimmunoprecipitation procedures, are available in
the Supplemental Data.
Chromatographic Analyses
LCB analysis was carried out as in Lester and Dickson (2001) with
some modifications. Normal- and reverse-phase TLC were carried
out as described in Kohlwein et al. (2001) and Paul et al. (2006), respec-
tively. GC/MS samples were prepared as in Browse et al. (1986) and
analyzed as described in Van Gilst et al. (2005).
Supplemental Data
Supplemental Data include Experimental Procedures, References,
and four figures and can be found with this article online at http://
www.cell.com/cgi/content/full/130/4/663/DC1/.ACKNOWLEDGMENTS
We would like to thank F. Szoka and Y.-A. Moon for general advice on
handling lipids; M. Van Gilst for introducing us to GC/MS and the Mass
Spectrometry Facility at UC Berkeley for allowing us the extensive use
of their instrument; H. Luecke for suggesting the chemical synthesis of
the dehydratase substrate; N. Gushwa and J. Garrison for help with
LC/MS; Z. Newby for insight into membrane protein expression in bac-
teria; R. Hegde for advice on reconstituting membrane proteins into
proteoliposomes; S. Kreft for experimental tips on using the dual topol-
ogy reporter; M. Schuldiner for initial studies into the function of Phs1p;
W.J. Lennarz, P. Walter, and R. Stroud for reagents; B. Toyama for
generous help with graphics; J. Taunton for encouragement and stim-
ulating discussions; M. Nirenberg for drawing the parallel between
Elops and calipers; D. Mullins, J. Taunton, D. Breslow, S. Collins, C.
Patil, J. Newman, R. Farese, K. Ashrafi, and J. Cox as well as members
of the Weissman lab for critical reading of the manuscript. The Howard
Hughes Medical Institute supported this work.
Received: April 30, 2007
Revised: May 31, 2007
Accepted: June 12, 2007
Published: August 23, 2007
REFERENCES
Alberts, B., Johnson, A., Lewis, M., Raff, M., Roberts, K., and Walter, P.
(2002). Molecular Biology of the Cell, Fourth Edition (New York, NY:
Garland Science, Taylor & Francis Group).
Beaudoin, F., Michaelson, L.V., Hey, S.J., Lewis, M.J., Shewry, P.R.,
Sayanova, O., and Napier, J.A. (2000). Heterologous reconstitution in
yeast of the polyunsaturated fatty acid biosynthetic pathway. Proc.
Natl. Acad. Sci. USA 97, 6421–6426.
Beaudoin, F., Gable, K., Sayanova, O., Dunn, T., and Napier, J.A.
(2002). A Saccharomyces cerevisiae gene required for heterologous
fatty acid elongase activity encodes a microsomal beta-keto-reduc-
tase. J. Biol. Chem. 277, 11481–11488.
Bellec, Y., Harrar, Y., Butaeye, C., Darnet, S., Bellini, C., and Faure,
J.D. (2002). Pasticcino2 is a protein tyrosine phosphatase-like involved
in cell proliferation and differentiation in Arabidopsis. Plant J. 32, 713–
722.
Browse, J., McCourt, P.J., and Somerville, C.R. (1986). Fatty acid
composition of leaf lipids determined after combined digestion and
fatty acid methyl ester formation from fresh tissue. Anal. Biochem.
152, 141–145.
Cane, D.E., Walsh, C.T., and Khosla, C. (1998). Harnessing the biosyn-
thetic code: combinations, permutations, and mutations. Science 282,
63–68.
Cinti, D.L., Cook, L., Nagi, M.N., and Suneja, S.K. (1992). The fatty acid
chain elongation system of mammalian endoplasmic reticulum. Prog.
Lipid Res. 31, 1–51.
Da Costa, M., Bach, L., Landrieu, I., Bellec, Y., Catrice, O., Brown, S.,
De Veylder, L., Lippens, G., Inze, D., and Faure, J.D. (2006). Arabidop-
sis PASTICCINO2 is an antiphosphatase involved in regulation of
cyclin-dependent kinase A. Plant Cell 18, 1426–1437.
Denic, V., Quan, E.M., and Weissman, J.S. (2006). A luminal surveil-
lance complex that selects misfolded glycoproteins for ER-associated
degradation. Cell 126, 349–359.
Dickson, R.C., Sumanasekera, C., and Lester, R.L. (2006). Functions
and metabolism of sphingolipids in Saccharomyces cerevisiae. Prog.
Lipid Res. 45, 447–465.Cell 130, 663–677, August 24, 2007 ª2007 Elsevier Inc. 675
Ferrer, J.L., Jez, J.M., Bowman, M.E., Dixon, R.A., and Noel, J.P.
(1999). Structure of chalcone synthase and the molecular basis of plant
polyketide biosynthesis. Nat. Struct. Biol. 6, 775–784.
Graham, I.A., Larson, T., and Napier, J.A. (2007). Rational metabolic
engineering of transgenic plants for biosynthesis of omega-3 polyun-
saturates. Curr. Opin. Biotechnol. 18, 142–147.
Han, G., Gable, K., Kohlwein, S.D., Beaudoin, F., Napier, J.A., and
Dunn, T.M. (2002). The Saccharomyces cerevisiae YBR159w gene
encodes the 3-ketoreductase of the microsomal fatty acid elongase.
J. Biol. Chem. 277, 35440–35449.
Ivessa, A.S., Schneiter, R., and Kohlwein, S.D. (1997). Yeast acetyl-
CoA carboxylase is associated with the cytoplasmic surface of the
endoplasmic reticulum. Eur. J. Cell Biol. 74, 399–406.
Jakobsson, A., Westerberg, R., and Jacobsson, A. (2006). Fatty acid
elongases in mammals: their regulation and roles in metabolism.
Prog. Lipid Res. 45, 237–249.
Jenni, S., Leibundgut, M., Boehringer, D., Frick, C., Mikolasek, B., and
Ban, N. (2007). Structure of fungal fatty acid synthase and implications
for iterative substrate shuttling. Science 316, 254–261.
Kemp, S., Valianpour, F., Denis, S., Ofman, R., Sanders, R.J., Mooyer,
P., Barth, P.G., and Wanders, R.J. (2005). Elongation of very long-
chain fatty acids is enhanced in X-linked adrenoleukodystrophy. Mol.
Genet. Metab. 84, 144–151.
Kim, H., Melen, K., Osterberg, M., and von Heijne, G. (2006). A global
topology map of the Saccharomyces cerevisiae membrane proteome.
Proc. Natl. Acad. Sci. USA 103, 11142–11147.
Kniazeva, M., Crawford, Q.T., Seiber, M., Wang, C.Y., and Han, M.
(2004). Monomethyl branched-chain fatty acids play an essential role
in Caenorhabditis elegans development. PLoS Biol. 2, E257. 10.
1371/journal.pbio.0020257.
Kohlwein, S.D., Eder, S., Oh, C.S., Martin, C.E., Gable, K., Bacikova,
D., and Dunn, T. (2001). Tsc13p is required for fatty acid elongation
and localizes to a novel structure at the nuclear-vacuolar interface in
Saccharomyces cerevisiae. Mol. Cell. Biol. 21, 109–125.
Kunst, L., and Samuels, A.L. (2003). Biosynthesis and secretion of
plant cuticular wax. Prog. Lipid Res. 42, 51–80.
Lee, S.H., Stephens, J.L., Paul, K.S., and Englund, P.T. (2006). Fatty
acid synthesis by elongases in trypanosomes. Cell 126, 691–699.
Leonard, A.E., Kelder, B., Bobik, E.G., Chuang, L.T., Lewis, C.J.,
Kopchick, J.J., Mukerji, P., and Huang, Y.S. (2002). Identification
and expression of mammalian long-chain PUFA elongation enzymes.
Lipids 37, 733–740.
Leonard, A.E., Pereira, S.L., Sprecher, H., and Huang, Y.S. (2004).
Elongation of long-chain fatty acids. Prog. Lipid Res. 43, 36–54.
Lester, R.L., and Dickson, R.C. (2001). High-performance liquid chro-
matography analysis of molecular species of sphingolipid-related long
chain bases and long chain base phosphates in Saccharomyces cer-
evisiae after derivatization with 6-aminoquinolyl-N-hydroxysuccini-
midyl carbamate. Anal. Biochem. 298, 283–292.
Livore, V.I., Tripodi, K.E., and Uttaro, A.D. (2007). Elongation of polyun-
saturated fatty acids in trypanosomatids. FEBS J. 274, 264–274.
Lomakin, I.B., Xiong, Y., and Steitz, T.A. (2007). The Crystal Structure
of Yeast Fatty Acid Synthase, a Cellular Machine with Eight Active
Sites Working Together. Cell 129, 319–332.
Matsuoka, K., and Schekman, R. (2000). The use of liposomes to study
COPII- and COPI-coated vesicle formation and membrane protein
sorting. Methods 20, 417–428.
McMahon, A., Butovich, I.A., Mata, N.L., Klein, M., Ritter, R., 3rd,
Richardson, J., Birch, D.G., Edwards, A.O., and Kedzierski, W.
(2007). Retinal pathology and skin barrier defect in mice carrying a Star-
gardt disease-3 mutation in elongase of very long chain fatty acids-4.
Mol. Vis. 13, 258–272.676 Cell 130, 663–677, August 24, 2007 ª2007 Elsevier Inc.Moon, Y.A., Shah, N.A., Mohapatra, S., Warrington, J.A., and Horton,
J.D. (2001). Identification of a mammalian long chain fatty acyl elon-
gase regulated by sterol regulatory element-binding proteins. J. Biol.
Chem. 276, 45358–45366.
Nugteren, D.H. (1965). The enzymic chain elongation of fatty acids by
rat-liver microsomes. Biochim. Biophys. Acta 106, 280–290.
Oh, C.S., Toke, D.A., Mandala, S., and Martin, C.E. (1997). ELO2 and
ELO3, homologues of the Saccharomyces cerevisiae ELO1 gene,
function in fatty acid elongation and are required for sphingolipid for-
mation. J. Biol. Chem. 272, 17376–17384.
Paul, S., Gable, K., Beaudoin, F., Cahoon, E., Jaworski, J., Napier,
J.A., and Dunn, T.M. (2006). Members of the Arabidopsis FAE1-like
3-Ketoacyl-CoA synthase gene family substitute for the Elop proteins
of Saccharomyces cerevisiae. J. Biol. Chem. 281, 9018–9029.
Pecoul, B. (2004). New drugs for neglected diseases: from pipeline to
patients. PLoS Med. 1, e6. 10.1371/journal.pmed.001006.
Pele, M., Tiret, L., Kessler, J.L., Blot, S., and Panthier, J.J. (2005). SINE
exonic insertion in the PTPLA gene leads to multiple splicing defects
and segregates with the autosomal recessive centronuclear myopathy
in dogs. Hum. Mol. Genet. 14, 1417–1427.
Poulos, A., Beckman, K., Johnson, D.W., Paton, B.C., Robinson, B.S.,
Sharp, P., Usher, S., and Singh, H. (1992). Very long-chain fatty acids in
peroxisomal disease. Adv. Exp. Med. Biol. 318, 331–340.
Puyaubert, J., Garcia, C., Chevalier, S., and Lessire, R. (2005). Acyl-
CoA elongase, a key enzyme in the development of high-erucic acid
rapeseed? Eur. J. Lipid Sci. Technol. 107, 263–267.
Rossler, H., Rieck, C., Delong, T., Hoja, U., and Schweizer, E. (2003).
Functional differentiation and selective inactivation of multiple Saccha-
romyces cerevisiae genes involved in very-long-chain fatty acid syn-
thesis. Mol. Genet. Genomics 269, 290–298.
Schneiter, R., Hitomi, M., Ivessa, A.S., Fasch, E.V., Kohlwein, S.D., and
Tartakoff, A.M. (1996). A yeast acetyl coenzyme A carboxylase mutant
links very-long-chain fatty acid synthesis to the structure and function
of the nuclear membrane-pore complex. Mol. Cell. Biol. 16, 7161–
7172.
Schneiter, R., Brugger, B., Amann, C.M., Prestwich, G.D., Epand, R.F.,
Zellnig, G., Wieland, F.T., and Epand, R.M. (2004). Identification
and biophysical characterization of a very-long-chain-fatty-acid-
substituted phosphatidylinositol in yeast subcellular membranes. Bio-
chem. J. 381, 941–949.
Schuldiner, M., Collins, S.R., Thompson, N.J., Denic, V., Bhamidipati,
A., Punna, T., Ihmels, J., Andrews, B., Boone, C., Greenblatt, J.F., et al.
(2005). Exploration of the function and organization of the yeast early
secretory pathway through an epistatic miniarray profile. Cell 123,
507–519.
Shanklin, J., Whittle, E., and Fox, B.G. (1994). Eight histidine residues
are catalytically essential in a membrane-associated iron enzyme,
stearoyl-CoA desaturase, and are conserved in alkane hydroxylase
and xylene monooxygenase. Biochemistry 33, 12787–12794.
Smith, S., Witkowski, A., and Joshi, A.K. (2003). Structural and func-
tional organization of the animal fatty acid synthase. Prog. Lipid Res.
42, 289–317.
Toulmay, A., and Schneiter, R. (2007). Lipid-dependent surface trans-
port of the proton pumping ATPase: a model to study plasma mem-
brane biogenesis in yeast. Biochimie 89, 249–254.
Tsuji, S., Ohno, T., Miyatake, T., Suzuki, A., and Yamakawa, T. (1984).
Fatty acid elongation activity in fibroblasts from patients with adreno-
leukodystrophy (ALD). J. Biochem. (Tokyo) 96, 1241–1247.
Van Gilst, M.R., Hadjivassiliou, H., Jolly, A., and Yamamoto, K.R.
(2005). Nuclear hormone receptor NHR-49 controls fat consumption
and fatty acid composition in C. elegans. PLoS Biol. 3, e53. 10.1371/
journal.pbio.0030053.
Vasireddy, V., Uchida, Y., Salem, N., Jr., Kim, S.Y., Mandal, M.N.,
Reddy, G.B., Bodepudi, R., Alderson, N.L., Brown, J.C., Hama, H.,
et al. (2007). Loss of functional ELOVL4 depletes very long-chain fatty
acids (> or =C28) and the unique omega-O-acylceramides in skin lead-
ing to neonatal death. Hum. Mol. Genet. 16, 471–482.
Welch, J.W., and Burlingame, A.L. (1973). Very long-chain fatty acids in
yeast. J. Bacteriol. 115, 464–466.Westerberg, R., Mansson, J.E., Golozoubova, V., Shabalina, I.G., Back-
lund, E.C., Tvrdik, P., Retterstol, K., Capecchi, M.R., and Jacobsson, A.
(2006). ELOVL3 is an important component for early onset of lipid recruit-
ment in brown adipose tissue. J. Biol. Chem. 281, 4958–4968.
Wu, G., Truksa, M., Datla, N., Vrinten, P., Bauer, J., Zank, T., Cirpus, P.,
Heinz, E., and Qiu, X. (2005). Stepwise engineering to produce high
yields of very long-chain polyunsaturated fatty acids in plants. Nat.
Biotechnol. 23, 1013–1017.Cell 130, 663–677, August 24, 2007 ª2007 Elsevier Inc. 677
